PL2099462T3 - Preparat farmaceutyczny do leczenia schorzeń zapalnych przewodu moczowo-płciowego - Google Patents

Preparat farmaceutyczny do leczenia schorzeń zapalnych przewodu moczowo-płciowego

Info

Publication number
PL2099462T3
PL2099462T3 PL07818284T PL07818284T PL2099462T3 PL 2099462 T3 PL2099462 T3 PL 2099462T3 PL 07818284 T PL07818284 T PL 07818284T PL 07818284 T PL07818284 T PL 07818284T PL 2099462 T3 PL2099462 T3 PL 2099462T3
Authority
PL
Poland
Prior art keywords
treatment
pharmaceutical preparation
kda
molecular weight
average molecular
Prior art date
Application number
PL07818284T
Other languages
English (en)
Inventor
Anna-Maria Vestweber
Original Assignee
Farco Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farco Gmbh filed Critical Farco Gmbh
Publication of PL2099462T3 publication Critical patent/PL2099462T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
PL07818284T 2006-12-12 2007-09-20 Preparat farmaceutyczny do leczenia schorzeń zapalnych przewodu moczowo-płciowego PL2099462T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102006058776 2006-12-12
DE102006060953A DE102006060953A1 (de) 2006-12-12 2006-12-20 Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
EP07818284A EP2099462B1 (de) 2006-12-12 2007-09-20 Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes
PCT/EP2007/008194 WO2008071245A1 (de) 2006-12-12 2007-09-20 Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes

Publications (1)

Publication Number Publication Date
PL2099462T3 true PL2099462T3 (pl) 2011-11-30

Family

ID=38820294

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07818284T PL2099462T3 (pl) 2006-12-12 2007-09-20 Preparat farmaceutyczny do leczenia schorzeń zapalnych przewodu moczowo-płciowego

Country Status (7)

Country Link
EP (1) EP2099462B1 (pl)
AT (1) ATE511847T1 (pl)
DE (2) DE102006060953A1 (pl)
DK (1) DK2099462T3 (pl)
PL (1) PL2099462T3 (pl)
SI (1) SI2099462T1 (pl)
WO (1) WO2008071245A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009035586A1 (de) * 2009-07-31 2011-02-03 Fresenius Kabi Deutschland Gmbh Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs
FR2954340B1 (fr) * 2009-12-23 2013-02-01 Eads Europ Aeronautic Defence Revetement multifonctionnel pour aeronefs
IT1402382B1 (it) 2010-09-09 2013-09-04 Ibsa Inst Biochimique Sa Complessi cooperativi ibridi di acido ialuronico
CN102210682B (zh) * 2011-04-29 2012-08-01 山东弘立医学动物实验研究有限公司 四氢嘧啶及其衍生物在制备治疗膀胱炎的药物中的应用
CN102258520B (zh) * 2011-04-29 2012-10-03 济南环肽医药科技有限公司 一种预防或治疗化疗引发的膀胱炎的药物组合物
DE202012000250U1 (de) 2011-11-24 2012-12-05 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die topische Anwendung I
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
RU2519010C1 (ru) * 2013-03-20 2014-06-10 Общество с ограниченной ответственностью "КОЛЕТЕКС" Композиция для лечения цистита
FR3020570B1 (fr) 2014-04-30 2017-07-21 Pierre Fabre Dermo-Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
CN105982912A (zh) * 2015-03-02 2016-10-05 黄绣川 一种包含透明质酸钠和硫酸软骨素的药物组合物
DE102016119183B4 (de) 2016-06-10 2019-05-16 Farco-Pharma Gmbh Medizinische Zusammensetzung, insbesondere in Form eines medizinischen Gels, und ihre Verwendung
EP3400949B1 (de) * 2017-05-12 2021-01-27 Farco-Pharma GmbH Zusammensetzung für die topische anwendung, insbesondere zur blaseninstillation
EP3400950B1 (de) * 2017-05-12 2019-11-13 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (20 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
EP3400951B1 (de) * 2017-05-12 2019-12-11 Farco-Pharma GmbH Blaseninstillationszusammensetzung enthaltend chondoitinsulfat (4,5 mg/ml), hyaluronsäure (16 mg/ml) und phosphatpuffer (ph 6,1 bis 7,9) mit erhöhter lagerstabiliät zur behandlung von cystitis
EP3415163B1 (de) * 2017-06-13 2023-02-22 Farco-Pharma GmbH Zusammensetzung mit lokalanästhetischer wirkung und deren verwendung
CN113041405B (zh) * 2021-03-22 2022-06-10 山东华熙海御生物医药有限公司 一种含透明质酸和四氢嘧啶的人体润滑液及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4244580A1 (de) 1992-12-31 1994-07-07 Galinski Erwin A Verfahren zur in vivo Gewinnung von Inhaltsstoffen aus Zellen
IN181358B (pl) 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US20020025921A1 (en) 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
DE69916643T2 (de) 1998-10-22 2005-04-28 Bioniche Life Sciences Inc., London Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
AU2001281368B2 (en) * 2000-07-31 2005-07-28 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
PT1708722E (pt) * 2004-01-28 2014-09-12 Univ California Nova terapia interstciial para o alívio imediato dos sintomas e terapia crónica na cistite intersticial
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes

Also Published As

Publication number Publication date
DE202007001059U1 (de) 2008-02-07
EP2099462B1 (de) 2011-06-08
EP2099462A1 (de) 2009-09-16
SI2099462T1 (sl) 2012-01-31
DE102006060953A1 (de) 2008-08-07
DK2099462T3 (da) 2011-09-26
ATE511847T1 (de) 2011-06-15
WO2008071245A1 (de) 2008-06-19

Similar Documents

Publication Publication Date Title
PL2099462T3 (pl) Preparat farmaceutyczny do leczenia schorzeń zapalnych przewodu moczowo-płciowego
KR101584824B1 (ko) 건성 점막 치료용 오스모라이트-함유 제제
US6656925B2 (en) Composition and method of treating arthritis
JP2004535430A5 (pl)
RU2013125021A (ru) Местные композиции для сохранения или восстановления целостности слизистых оболочек
ITMI20130075A1 (it) Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
US11337992B2 (en) Liquid composition for use in the treatment of gastroesophageal reflux
WO2006085143A3 (en) Improved bioactive agent compositions for repair of cell injuries
CA2632207C (en) Use of calcitonin for the treatment of ra
WO2018100468A1 (en) Oral composition for the treatment of gastroesophageal reflux and laryngopharyngeal reflux
HRP20150949T1 (hr) UPORABA 24-norUDCA
EP2251016A3 (en) Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
EP3773615B1 (en) Liquid composition for use in the treatment of the mucosa of the oro-pharyngo-laryngo-esophageal tract
EP3548041A1 (en) Composition for the treatment of gastroesophageal reflux comprising hyaluronic acid
JP7084930B2 (ja) 炎症性腸疾患及び腸管大腸炎を処置するのに使用するための組成物
EP1162937B1 (fr) Compositions a base d'un sulfate de chondroitine et de chitosan pour prevenir ou traiter les affections rhumatologiques par voie generale
CN103655601A (zh) 一种用于膀胱灌洗的组合物
WO2017098396A1 (en) Synergistic combination of pyrrolidone carboxylic acid and/or salts thereof and hyaluronic acid and/or salts thereof, for use in the treatment and/or prevention of dryness and irritation of the mucosae, and related pharmaceutical formulations
ES2286698T3 (es) Composicion farmaceutica que comprende un complejo de hialuronato de zinc para el tratamiento de la esclerosis multiple.
CA2516318A1 (en) Use of glycosaminoglycans such as heparin for the treatment of respiratory disorders such as copd
JP2009505992A (ja) ヒアルロン酸と活性炭とを含む酒酔い軽減用組成物
Mahima et al. Use of chitosan mouth-wash in radio-chemotherapy induced oral mucositis: A case-control study
ES2325392B1 (es) Composicion para el tratamiento de la artrosis.
WO2006039709A1 (en) Methods using glycosaminoglycans for the treatment of kidney disease
WO2008120965A1 (es) Composición farmaceutica que comprende la combinación de un agente antiartrítico, un agente condroprotector y un agente antiinflamatorio.